TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. ANESTHESIA DRUGS MARKET, BY DRUG TYPE (USD BILLION)
6.1. General Anesthesia
6.2. Local Anesthesia
6.3. Sedative Agents
6.4. Regional Anesthesia
7. ANESTHESIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
7.1. Injectable
7.2. Inhalation
7.3. Topical
8. ANESTHESIA DRUGS MARKET, BY END USE (USD BILLION)
8.1. Hospitals
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Centers
9. ANESTHESIA DRUGS MARKET, BY FORMULATION (USD BILLION)
9.1. Liquid
9.2. Gas
9.3. Solid
10. ANESTHESIA DRUGS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Anesthesia Drugs Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Anesthesia Drugs Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Zydus Cadila
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. AbbVie
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Air Products and Chemicals
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Glenmark Pharmaceuticals
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Fresenius Kabi
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Hikma Pharmaceuticals
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Baxter International
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Mallinckrodt Pharmaceuticals
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Mylan
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Medaenen
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Pfizer
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Salix Pharmaceuticals
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. AstraZeneca
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Novartis
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 9. US ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 10. US ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 11. US ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 29. UK ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 30. UK ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 31. UK ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 58. APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 59. APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 60. APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 61. APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 128. MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 129. MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 130. MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 131. MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA ANESTHESIA DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA ANESTHESIA DRUGS MARKET ANALYSIS
FIGURE 3. US ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 4. US ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 5. US ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 6. US ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 7. US ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 9. CANADA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 10. CANADA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 11. CANADA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 12. CANADA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE ANESTHESIA DRUGS MARKET ANALYSIS
FIGURE 14. GERMANY ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 15. GERMANY ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 16. GERMANY ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 17. GERMANY ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 18. GERMANY ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 20. UK ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 21. UK ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 22. UK ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 23. UK ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 25. FRANCE ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 26. FRANCE ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 27. FRANCE ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 28. FRANCE ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 30. RUSSIA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 31. RUSSIA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 32. RUSSIA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 33. RUSSIA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 35. ITALY ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 36. ITALY ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 37. ITALY ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 38. ITALY ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 40. SPAIN ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 41. SPAIN ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 42. SPAIN ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 43. SPAIN ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 45. REST OF EUROPE ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 46. REST OF EUROPE ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 47. REST OF EUROPE ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 48. REST OF EUROPE ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC ANESTHESIA DRUGS MARKET ANALYSIS
FIGURE 50. CHINA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 51. CHINA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 52. CHINA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 53. CHINA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 54. CHINA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 56. INDIA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 57. INDIA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 58. INDIA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 59. INDIA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 61. JAPAN ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 62. JAPAN ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 63. JAPAN ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 64. JAPAN ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 66. SOUTH KOREA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 67. SOUTH KOREA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 68. SOUTH KOREA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 69. SOUTH KOREA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 71. MALAYSIA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 72. MALAYSIA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 73. MALAYSIA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 74. MALAYSIA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 76. THAILAND ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 77. THAILAND ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 78. THAILAND ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 79. THAILAND ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 81. INDONESIA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 82. INDONESIA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 83. INDONESIA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 84. INDONESIA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 86. REST OF APAC ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 87. REST OF APAC ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 88. REST OF APAC ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 89. REST OF APAC ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA ANESTHESIA DRUGS MARKET ANALYSIS
FIGURE 91. BRAZIL ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 92. BRAZIL ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 93. BRAZIL ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 94. BRAZIL ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 95. BRAZIL ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 97. MEXICO ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 98. MEXICO ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 99. MEXICO ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 100. MEXICO ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 102. ARGENTINA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 103. ARGENTINA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 104. ARGENTINA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 105. ARGENTINA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 107. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 108. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 109. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 110. REST OF SOUTH AMERICA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA ANESTHESIA DRUGS MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 113. GCC COUNTRIES ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 114. GCC COUNTRIES ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 115. GCC COUNTRIES ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 116. GCC COUNTRIES ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 118. SOUTH AFRICA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 119. SOUTH AFRICA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 120. SOUTH AFRICA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 121. SOUTH AFRICA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA ANESTHESIA DRUGS MARKET ANALYSIS BY DRUG TYPE
FIGURE 123. REST OF MEA ANESTHESIA DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 124. REST OF MEA ANESTHESIA DRUGS MARKET ANALYSIS BY END USE
FIGURE 125. REST OF MEA ANESTHESIA DRUGS MARKET ANALYSIS BY FORMULATION
FIGURE 126. REST OF MEA ANESTHESIA DRUGS MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF ANESTHESIA DRUGS MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF ANESTHESIA DRUGS MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: ANESTHESIA DRUGS MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: ANESTHESIA DRUGS MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: ANESTHESIA DRUGS MARKET
FIGURE 133. ANESTHESIA DRUGS MARKET, BY DRUG TYPE, 2024 (% SHARE)
FIGURE 134. ANESTHESIA DRUGS MARKET, BY DRUG TYPE, 2019 TO 2032 (USD Billions)
FIGURE 135. ANESTHESIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 136. ANESTHESIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2032 (USD Billions)
FIGURE 137. ANESTHESIA DRUGS MARKET, BY END USE, 2024 (% SHARE)
FIGURE 138. ANESTHESIA DRUGS MARKET, BY END USE, 2019 TO 2032 (USD Billions)
FIGURE 139. ANESTHESIA DRUGS MARKET, BY FORMULATION, 2024 (% SHARE)
FIGURE 140. ANESTHESIA DRUGS MARKET, BY FORMULATION, 2019 TO 2032 (USD Billions)
FIGURE 141. ANESTHESIA DRUGS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. ANESTHESIA DRUGS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS